Author Correction: Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease

Affiliations

• ¹ Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.
• ² Translational Gastroenterology Unit, University of Oxford, Oxford, UK.
• ³ Dr. von Hauner Children's Hospital, Department of Pediatrics, University Hospital, Ludwig Maximilians University, Munich, Germany.
• ⁴ Great Ormond Street Hospital, London, UK.
• ⁵ Blizard Institute, Barts and the London School of Medicine, Queen Mary University of London, London, UK.
• ⁶ The Royal London Children's Hospital, Barts Health NHS Trust, London, UK.
• ⁷ Universitätsklinikum, Ulm, Germany.
• ⁸ Department of Paediatrics, University of Oxford, Oxford, UK.
• ⁹ Royal Hospital for Children, Glasgow, UK.
• ¹⁰ Alder Hey Children's Hospital, Liverpool, UK.
• ¹¹ Addenbrooke's Hospital, Cambridge, UK.
• ¹² Department of Paediatrics, Gastroenterology and Nutrition, Jagiellonian University Medical College, Krakow, Poland.
• ¹³ Division of Gastroenterology and Nutrition and Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland.
• ¹⁴ Institute of Genetics and Molecular Medicine, University of Edinburgh, Scotland, UK.
• ¹⁵ IBD Research Unit, Department of Gastroenterology, Addenbrooke's Hospital, Cambridge, UK.
• ¹⁶ NIHR Blood and Transplant Research Unit in Donor Health and Genomics, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
• ¹⁷ INTERVAL Coordinating Centre, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
• ¹⁸ Department of Haematology, University of Cambridge, Cambridge, UK.
• ¹⁹ NHS Blood and Transplant - Oxford Centre, Level 2, John Radcliffe Hospital, Oxford, UK.
• ²⁰ Biomedical Research Centre, Oxford - Haematology Theme, Radcliffe Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.
• ²¹ Weatherall Institute of Molecular Medicine and the Radcliffe Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.
• ²² National Institute of Health Research Oxford Biomedical Research Centre, Surgical Innovation and Evaluation and Molecular Diagnostics Themes, University of Oxford, Oxford, UK.
• ²³ Department of Biochemistry and Pediatrics, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
• ²⁴ SickKids Inflammatory Bowel Disease Centre and Cell Biology Program, Research Institute, Hospital for Sick Children, Toronto, ON, Canada.
• ²⁵ Division of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Boston, MA, USA.
• ²⁶ Harvard Medical School, Boston, MA, USA.
• ²⁷ Division of Gastroenterology, Brigham and Women's Hospital, Boston, MA, USA.
• ²⁸ Child Life and Health, University of Edinburgh, Edinburgh, UK.
• ²⁹ Translational Gastroenterology Unit, University of Oxford, Oxford, UK. holm.uhlig@ndm.ox.ac.uk.
• ³⁰ Department of Paediatrics, University of Oxford, Oxford, UK. holm.uhlig@ndm.ox.ac.uk.
• ³¹ Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK. carl.anderson@sanger.com.